Adalimumab passes to newborn
Published May 8, 2011
Post
Article from the health outcomes explored at Digestive Disease Week 2011 shows that infants exposed in utero to Adalimumab, aka Humira, will have it linger in their system and it will be in the cord blood:
“At a minimum, it can be detected to three months from birth,” Dr. Mahadevan noted.
Link to article.
Like this: Like Loading...
Related
Archives
Select Month
October 2017
September 2017
August 2017
April 2016
March 2016
December 2015
November 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
October 2014
March 2014
February 2014
September 2013
August 2013
May 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
June 2010
May 2010
April 2010
March 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
Eating SCD 
0 Responses to “Adalimumab passes to newborn”